Tags

Type your tag names separated by a space and hit enter

Laser therapy for the restoration of vaginal function.
Maturitas. 2017 May; 99:10-15.M

Abstract

Laser therapy has a therapeutic role in various medical conditions and most recently has gained interest as a non-hormonal treatment for genitourinary syndrome of menopause (GSM) and as a non-invasive option for stress urinary incontinence (SUI). Several therapies are available to alleviate GSM symptoms, including hormonal and non-hormonal products. Both microablative fractional CO2 laser and the non-ablative vaginal Er:YAG laser (VEL) induce morphological changes in the vaginal tissues, and data from non-randomized clinical trials suggest that laser therapy can alleviate vaginal dryness and dyspareunia. VEL has been reported to improve SUI as well as vaginal prolapse. Although large randomized trials have not been reported, the evidence suggests that VEL can be offered as a safe and efficacious alternative to hormone replacement therapy (HRT) for GSM, as well as a first-line treatment for mild to moderate SUI, before surgical procedures are resorted to. Randomized studies are needed to compare laser treatments with other therapies, as well as to assess the duration of the therapeutic effects and the safety of repeated applications. Research is presently evaluating both an automated robotic probe for VEL treatments and an intraurethral probe for the treatment of severe and type III SUI.

Authors+Show Affiliations

Department of Obstetrics and Gynaecology, Pisa University Hospital, Pisa, Italy. Electronic address: margamba54@gmail.com.Palacios Institute of Womeńs Health, Madrid, Spain.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

28364861

Citation

Gambacciani, Marco, and Santiago Palacios. "Laser Therapy for the Restoration of Vaginal Function." Maturitas, vol. 99, 2017, pp. 10-15.
Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10-15.
Gambacciani, M., & Palacios, S. (2017). Laser therapy for the restoration of vaginal function. Maturitas, 99, 10-15. https://doi.org/10.1016/j.maturitas.2017.01.012
Gambacciani M, Palacios S. Laser Therapy for the Restoration of Vaginal Function. Maturitas. 2017;99:10-15. PubMed PMID: 28364861.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laser therapy for the restoration of vaginal function. AU - Gambacciani,Marco, AU - Palacios,Santiago, Y1 - 2017/02/04/ PY - 2016/10/12/received PY - 2017/01/16/revised PY - 2017/01/25/accepted PY - 2017/4/3/entrez PY - 2017/4/4/pubmed PY - 2017/6/3/medline KW - Genitourinary syndrome of menopause KW - Pelvic organ prolapse KW - Urinary incontinence KW - Vaginal laser therapy KW - Vaginal relaxation syndrome SP - 10 EP - 15 JF - Maturitas JO - Maturitas VL - 99 N2 - Laser therapy has a therapeutic role in various medical conditions and most recently has gained interest as a non-hormonal treatment for genitourinary syndrome of menopause (GSM) and as a non-invasive option for stress urinary incontinence (SUI). Several therapies are available to alleviate GSM symptoms, including hormonal and non-hormonal products. Both microablative fractional CO2 laser and the non-ablative vaginal Er:YAG laser (VEL) induce morphological changes in the vaginal tissues, and data from non-randomized clinical trials suggest that laser therapy can alleviate vaginal dryness and dyspareunia. VEL has been reported to improve SUI as well as vaginal prolapse. Although large randomized trials have not been reported, the evidence suggests that VEL can be offered as a safe and efficacious alternative to hormone replacement therapy (HRT) for GSM, as well as a first-line treatment for mild to moderate SUI, before surgical procedures are resorted to. Randomized studies are needed to compare laser treatments with other therapies, as well as to assess the duration of the therapeutic effects and the safety of repeated applications. Research is presently evaluating both an automated robotic probe for VEL treatments and an intraurethral probe for the treatment of severe and type III SUI. SN - 1873-4111 UR - https://www.unboundmedicine.com/medline/citation/28364861/Laser_therapy_for_the_restoration_of_vaginal_function_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5122(16)30266-3 DB - PRIME DP - Unbound Medicine ER -